Implications of the 2009 American Joint Committee on Cancer Melanoma Staging and Classification on dermatologists and their patients

Seminars in Cutaneous Medicine and Surgery

Volumn 29, Issue 3, 2010, Pages 142-147

  Nading, Mary Alice ^a   Balch, Charles M ^b   Sober, Arthur J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; DISTANT METASTASIS; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MELANOMA; MITOSIS; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE;

HUMANS; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SKIN NEOPLASMS;

EID: 78049524421     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2010.06.004     Document Type: Review

References (10)

1. Melanoma of the skin. AJCC Cancer Staging Manual 2010, 325-344. Springer, New York. (edition 7). S.B. Edge, D.R. Byrd, C.C. Compton (Eds.).
2. Gershenwald J.E., Soong S.J., Balch C.M. American Joint Committee on Cancer (AJCC) Melanoma Staging Committee: 2010 TNM staging system for cutaneous melanoma... and beyond. Ann Surg Oncol 2010, 17:1475-1477.
3. Balch C.M., Gershenwald J.E., Soong S.J., et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009, 27:6199-6206.
4. Balch C.M., Buzaid A.C., Soong S.J., et al. Final Version of the American Joint Committee on Cancer Staging System for cutaneous melanoma. J Clin Oncol 2001, 19:3635-3648.
5. Balch C.M., Buzaid A.C., Soong S.J., et al. New TNM Melanoma Staging System: linking biology and natural history to clinical outcomes. Semin Surg Oncol 2003, 21:43-52.
6. Andtbacka R.H., Gershenwald J.E. Role of sentinel lymph node biopsy in patients with thin melanomas. J Natl Compr Cancer Netw 2009, 7:308-317.
7. Kesmodel S.B., Karakousis G.C., Botbyl J.D., et al. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol 2005, 12:1-10.
8. Balch C.M., Gershenwald J.E., Soong S.J., et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol 2010, 28:2452-2459.
9. Petitt M., Allison A., Shimoni T., et al. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma. J Am Acad Dermatol 2009, 61:819-828.
10. Zbytek B., Carlson J.A., Granese J., et al. Current concepts of metastatic melanoma. Expert Rev Dermatol 2008, 3:569-585.